Healthcare is Broken—This Company Wants to Fix It
Summary
Ed Elson interviews Hims & Hers CEO Andrew Dudum about disrupting healthcare by addressing stigmatized conditions like sexual health and hair loss. Dudum explains how the company leveraged telehealth to normalize these conversations and expand into broader wellness. They discuss the strategic decision to go public via SPAC, the impact of compounding GLP-1 drugs during shortages, and efforts to force price transparency and personalization in the pharmaceutical industry.
Topics discussed
Sponsor message from Engine
Introduction to Hims & Hers and Andrew Dudum
The consumerization of healthcare and company origins
Strategic focus on hair loss and erectile dysfunction
Addressing male loneliness and normalizing health issues
Going public: IPO strategy and market discipline
Managing stock volatility and team morale
GLP-1 drugs, compounding, and price disruption
Regulation, peptides, and safety standards
Sponsor message from Engine
The societal impact of GLP-1s and obesity
Future of pharma: Preventative vs. reactive care
Vertical integration and disrupting legacy healthcare
Advice for founders: Finding the wedge
Outro and final sponsor message
Listen ad-free on Castria